Mesothelioma is an aggressive cancer affecting the membrane lining of the lungs and abdomen.
Malignant mesothelioma is the most serious of all
asbestos-related diseases. The primary cause and risk factor for mesothelioma
is exposure to asbestos.
Making a correct mesothelioma diagnosis is particularly difficult for
doctors because the disease often presents with symptoms that mimic other
common ailments. There is no known cure for mesothelioma, but treatments such
as surgery and chemotherapy have helped to improve the typical mesothelioma prognosis.
Pleural mesothelioma (affecting the lung’s protective
lining in the chest cavity) represents about three quarters of all mesothelioma
incidence. Peritoneal mesothelioma, which affects the abdominal cavity,
and pericardial mesothelioma, which affects the cardiac cavity, comprises
the remainder.
There are three recognized mesothelioma cell-types.
Between 50 and 70% of all mesotheliomas are of the epithelial variety. While
prognosis is generally poor, it is considered less aggressive than sarcomatoid
mesothelioma and biphasic mesothelioma, which comprise the remainder of cell
type diagnoses.
The cavities within the body encompassing the
chest, abdomen, and heart are surround by a membrane of cells known as the
mesothelium. Mesothelial cells assist in general organ functions. The
mesothelium is particularly important to organs that are commonly in motion,
such as expansion or contraction of the lungs, stomach, or heart. Lubrication
from the mesothelial cells allows free range of motion within the body. The
mesothelium of the chest, abdomen, and cardiac cavity are called the pleura,
the peritoneum, and the pericardium, respectively. Each of these groupings of
mesothelial cells is extremely critical to the functions of the body structures
which they encompass.
Malignancies (cancerous tumors) occurring within
the mesothelial membranes are known as malignant mesothelioma, or simply
mesothelioma. Benign tumors of the mesothelium are known to occur, but are much
more rare than malignant mesothelial tumors.
While tumors of
the mesothelium were first recognized in the late 18th century, it was not
until the middle of the 20th century that this particular cancer was studied
and examined with more detail. It was at this time when suspicions of the
cancer’s causal relationship with asbestos
exposure became more substantiated. A joint research venture
through the Department of Thoracic Surgery at the University of the Witswater
and Johannesburg General Hospital in South Africa provided the most compelling
evidence of the nexus between asbestos exposure and the development of pleural
mesothelioma.
Incidence of mesothelioma is still quite rare, with
only 2,500-3000 diagnoses in the United States each year. There was a spike in
reported diagnoses between 1970 and 1984, which has been attributed to the
latency period between diagnosis and the height of industrial exposures, which
occurred roughly 40-60 years prior to this time. Exposure was common in nearly
all industries but was particularly common in the WWII-era military industrial
cycle, including Navy Shipyards.
Although this cancer is much more common in men
over the age of 60 (largely attributed to the industrial exposures within
male-dominated industries), mesothelioma in women and children has been
described as well. Mesothelioma
causes for diagnosis in women and children are mainly
attributed to secondary exposure to asbestos, as it was not uncommon for men to
bring asbestos back into the home on their body or clothing if proper cleaning
facilities were not available on site.
Mesothelioma is diagnosed through a comprehensive
combination of biopsy and imaging scans.
Mesothelioma can be a difficult malignancy to
diagnose because the symptoms of the disease closely resemble other respiratory
conditions, and because the pathology can be very difficult to distinguish from
adenocarcinoma of the lung. For this reason, misdiagnosis is not uncommon in
mesothelioma patients. Symptoms of mesothelioma include chest pain, chronic
cough, effusions of the chest and abdomen, and the presence of blood in lung
fluid.
Diagnostic surgeries, including a biopsy, will
typically be required to determine the type of malignant cells that are present
in the body. Typically a body imaging scan, including a magnetic resonance
image (MRI), computer topography (CT scan), and/or positron emission tomography
(PET), will be required to determine the extent and location of the disease.
While mesothelioma is typically advanced at
diagnosis, treatment options are available.
Mesothelioma, while certainly an aggressive disease, is a manageable malignancy. While there is no cure
for the cancer, mesothelioma treatment options may potentially include
surgery, chemotherapy, and radiation therapy. A combination of Alimta® and
Cisplatin is currently the only FDA approved chemotherapy regimen, though
several clinical trials are currently in progress utilizing other drugs
including Gemcitabine and Onconase, that may lead to new treatment options that
provide a benefit for patients.
Radiation therapy is also utilized, but typically
in conjunction with other treatment methods like surgery and chemotherapy.
Surgical resection of mesothelioma is possible in early-stage-diagnosed
patients. Diagnostic and palliative procedures such as thoracentesis and
pleurodesis are also commonly performed in patients with malignant mesothelioma
in order to minimize cancer-related symptoms.
Alternative therapies have also been used
effectively by many mesothelioma patients to assist in managing symptoms of the
disease and conventional treatments.
Mesothelioma is caused by exposure to asbestos.
Mesothelioma is primarily caused by exposure to
asbestos, though cases have been documented in children or other individuals
with no asbestos history. Asbestos is a microscopic and naturally occurring
mineral that lodges in the pleural lining of the lungs and the peritoneal lining
of the abdominal cavity. In most cases, several years will pass (up to 60)
before mesothelioma develops in those who had been exposed to asbestos.
Source :http://www.mesothelioma.com/
No comments:
Post a Comment